e-learning
resources
ERJ
2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of initial antibiotic choice on mortality from pneumococcal pneumonia
Aspa J., Rajas O., Rodriguez de Cast... F., Huertas M. C., Borderias L., Cabello F. J., Tabara J., Hernandez-Flix S., Martinez-Sanchis A., Torres A.
Source:
Eur Respir J 2006; 27: 1010-1019
Journal Issue:
May
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Aspa J., Rajas O., Rodriguez de Cast... F., Huertas M. C., Borderias L., Cabello F. J., Tabara J., Hernandez-Flix S., Martinez-Sanchis A., Torres A.. Impact of initial antibiotic choice on mortality from pneumococcal pneumonia. Eur Respir J 2006; 27: 1010-1019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
S. pneumoniae
community-acquired pneumonia (SP-CAP): relationship between mortality and antibiotic susceptibility and risk factors for drug resistance
Source: Eur Respir J 2001; 18: Suppl. 33, 503s
Year: 2001
Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review
Source: Eur Respir J 2008; 31: 625-632
Year: 2008
Early mortality in patients with community-acquired pneumonia: causes and risk factors
Source: Eur Respir J 2008; 32: 733-739
Year: 2008
Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Source: Eur Respir J 2007; 30: 517-524
Year: 2007
Streptococcus pneumoniae
resistance pattern and its clinical implications
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia
Source: Eur Respir J 2010; 36: 1073-1079
Year: 2010
Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections
Source: Eur Respir J 2002; 20: 3S-8S
Year: 2002
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002
Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant
Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant
Staphylococcus aureus
(MRSA): a real hospital-based pathogen?
Year: 2006
Evolution of antimicrobial resistance trends in the last five years in patients with bacteremic Pneumococcal community-acquired pneumonia (CAP-SP)
Source: Eur Respir J 2005; 26: Suppl. 49, 639s
Year: 2005
Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013
Pulmonary disease as a risk factor for community-acquired pneumonia caused by multiple pathogens, including
Streptococcus pneumoniae
Source: Eur Respir J 2001; 18: Suppl. 33, 502s
Year: 2001
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor
Source: Eur Respir J 2004; 24 : 779-785
Year: 2004
Levofloxacin non-susceptible
streptococcus pneumoniae
in community-acquired respiratory infection; prevalence and risk factors
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Pneumococcal pneumonia: an old disease with radically-new approaches for antibiotic therapy
Source: Annual Congress 2005 - Outcome in severe pneumonia
Year: 2005
Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia
Source: Eur Respir J 2006 Oct 01;28(4):816-823
Year: 2006
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009
VAP: approach to therapy
Source: Eur Respir Mon 2011; 53: 36-47
Year: 2011
The impact of antibiotic resistance in the management of lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=131
Year: 2004
Antibiotic treatment for nosocomial pneumonia
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=211
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept